Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We investigate the management of prostate and bladder cancer, research into molecular mechanisms of cancer progression and biomarker research.

Surgical oncology NDS

Although cancer research activities in Surgery have taken place at Oxford for many years, the establishment of a Surgical Oncology Section within the Nuffield Department of Surgical Sciences, as part of the Oxford Cancer Research Centre, and affiliated to the Department of Oncology, has allowed for the first time the three major cancer treatment areas, i.e. radiation, drugs and surgery to be placed within a cohesive structure which facilitates translational research. 

Our research includes:

  • Management of urological malignancies, in particular prostate and bladder cancer. Phase III clinical trials, Chief Investigator, HTA NIHR ProtecT (Prostate testing for cancer and Treatment) study
  • Translational biomarker research
  • PI NCRI ProMPT (Prostate Mechanisms of Progression and Treatment) study 
  • Basic science research including molecular and epigenetic mechanisms of disease progression in prostate/bladder cancer.

For our research activities, we are developing a rich environment based on inter-disciplinary work with world-class researchers and resources at Oxford. We are locating young researchers and clinical academic trainees in the best and most suitable institutes, to match their area of interest, and allow them to be mentored and fostered jointly by senior clinical academics and senior scientists. 

Our team

Related research themes